Therapeutic Hypothermia Systems Market

Therapeutic Hypothermia Systems Market by Product (Cooling Devices, Cooling Catheters, Cool Caps), Application (Neurology, Cardiology, Neonatal Care), and Region (North America, Europe, Asia- Pacific, RoW) - Global Forecast to 2028

Report Code: MD 8924 Jan, 2024, by marketsandmarkets.com

The global therapeutic hypothermia systems market in terms of revenue was estimated to be worth $291 million in 2023 and is poised to reach $396 million by 2028, growing at a CAGR of 6.3% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The growth in this market is attributed to the increasing need for therapeutic hypothermia systems for cardiac arrest patients and the growing use of minimally invasive cooling techniques. However, alternative methods or techniques could restrain the growth of this market.

Attractive Opportunities in the Therapeutic Hypothermia Systems Market

Therapeutic Hypothermia  Systems Market

To know about the assumptions considered for the study, Request for Free Sample Report

Global Therapeutic Hypothermia Systems Dynamics

Therapeutic Hypothermia  Systems Market

DRIVER: Increasing number of surgical procedures

Effective therapeutic hypothermia management of patients is required to be made to maintain normothermia during surgical procedures with special consideration. Furthermore, managing intraoperative hypothermia is vital for eliminating surgical bleeding, surgical-site infections, and wound infections, which can lead to severe health complications, extended hospitalization periods, and an increase in patient mortality. Hypothermia is a common occurrence during surgeries as anesthetics can disrupt the normal body temperature of a patient, according to the American Society of Anaesthesiologists (ASA). The number of surgical procedures performed has increased over the years. According to the National Library of Medicine, globally, a staggering 310 million major surgeries are performed each year (around 40 to 50 million in the US and 20 million in Europe). The growing number of surgical procedures performed will drive the demand for therapeutic hypothermia systems.

RESTRAINT: Lack of awareness regarding therapeutic hypothermia systems in developing countries

Managing the core temperature of patients requires professionals with relevant experience and knowledge of the methodology to properly use the cooling systems. The need for proper training for effective usage of systems has been created by the players by launching the advanced systems in the market. These advancements avoid additional risks of high fever and hypothermia in pre-and post-operative setups and help in providing results of near-core and core temperature ranges. However, the major factors limiting their adoption are the lack of awareness among healthcare practitioners and doctors about advancements that are incorporated by manufacturers, coupled with a dearth of skilled personnel who can effectively operate and process these devices.

OPPORTUNITY: Increasing growth opportunities in developing countries

Countries like India, China, South Korea, Brazil, Taiwan, Turkey, Russia, and South Africa offer potential growth opportunities for major players operating in the market as these are emerging economies. This can be attributed to the rise in the geriatric population, the growing prevalence of chronic and infectious diseases, improvement in healthcare infrastructure, and growing disposable income in these countries.

CHALLENGE: Lack of skilled healthcare professionals

In developing countries, there is a shortage of physicians and healthcare professionals, and the proper usage of these devices requires expertise, relevant experience, and knowledge of the technology and its applications.

Currently, there is a shortage of skilled medical personnel in both developed and developing countries. According to WHO estimates, globally, there will be a shortage of 18 million healthcare workers by 2030. The Association of American Medical Colleges (AAMC) estimates that the US will face a shortage of approximately 54,100–139,000 physicians by 2033. This shortage of skilled professionals and physicians in healthcare will have an impact on the market.

Therapeutic Hypothermia Systems Market Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of therapeutic hypothermia systems. These companies have been operating in the market for several years and possess diversified product portfolios, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), and Stryker Corporation (US).

Therapeutic Hypothermia  Systems Market Ecosystem

In 2022, cooling devices segment to observe the highest growth rate of the therapeutic hypothermia systems industry, by product.

Based on the product, the therapeutic hypothermia systems market is classified as Cooling Catheters, Cooling devices, and Cool Caps. The cooling devices segment dominated the market in 2022. The large share of the segment can be attributed to the growing number of players in the therapeutic hypothermia systems and the rise in a number of cardiac arrest surgeries.

In 2022, neurology segment to dominate the therapeutic hypothermia systems industry, by application.

Based on the applications, the therapeutic hypothermia systems market is segmented into Neurology, Cardiology, Neonatal care, and other applications. The neurology segment dominated the global market in 2022. The large share of this segment can be primarily attributed to the growing prevalence of trauma brain injuries and the advantages of using therapeutic hypothermia in improving neurological outcomes.

In 2022, North America to dominate in therapeutic hypothermia systems industry.

The global therapeutic hypothermia systems market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to dominate during the forecast period, primarily due to the growing R&D expenditure by companies and the presence of major players in the US. Growth in the geriatric population, the rising incidence of cardiac arrests and neurological disorders, and the availability of technologically advanced products are the other factors supporting the growth of the market in North America.

Therapeutic Hypothermia  Systems Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The therapeutic hypothermia systems market is dominated by players such as ZOLL Medical Corporation (Japan), Becton, Dickinson and Company (US), and Stryker Corporation (US).

Scope of the Therapeutic Hypothermia Systems Industry

Report Metric

Details

Market Revenue in 2023

$291 million

Projected Revenue by 2028

$396 million

Revenue Rate

Poised to Grow at a CAGR of 6.3%

Market Driver

Increasing number of surgical procedures

Market Opportunity

Increasing growth opportunities in developing countries

This research report categorizes the Therapeutic hypothermia systems market to forecast revenue and analyze trends in each of the following submarkets:

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

By Product

  • Cooling Devices
  • Cooling Catheters
  • Cool Caps

By Application

  • Neurology
  • Cardiology
  • Neonatal Care
  • Other Application

Recent Developments of Therapeutic Hypothermia Systems Industry

  • In 2023, Asahi Kasei Corporation (Japan) signed an agreement with BrainCool, a medical device company specializing in therapeutic hypothermia systems solutions, for the exclusive distribution of the BrainCool System/IQool System and the IQool System Pads in the US and key markets in Europe.
  • In 2022, Gentherm acquired Jiangmen Dacheng Medical Equipment Co., Ltd., a manufacturer of medical materials and medical equipment, including patient therapeutic hypothermia solutions.
  • In 2021, ZOLL Medical (US) signed a distribution agreement with Wallaby Medical Technologies, wherein Wallaby will manage the sales and distribution of ZOLL’s therapeutic hypothermia products in China.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 25)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
                    FIGURE 1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY 
    1.5 STAKEHOLDERS 
    1.6 LIMITATIONS 

2 RESEARCH METHODOLOGY (Page No. - 29)
    2.1 RESEARCH DATA 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key industry insights
                    2.1.2.3 Breakdown of primary interviews
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
                                FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
           2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
                    FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION
           2.2.2 APPROACH 2: NUMBER OF THERAPEUTIC HYPOTHERMIA SYSTEMS
                    TABLE 1 REVENUE ESTIMATION APPROACH BY CALCULATING MARKET SIZE OF THERAPEUTIC HYPOTHERMIA SYSTEMS
           2.2.3 APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
           2.2.4 APPROACH 4: PRIMARY INTERVIEWS
                    FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
                    FIGURE 8 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN & DATA TRIANGULATION 
          FIGURE 9 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ANALYSIS 
    2.5 MARKET ASSUMPTIONS 
    2.6 RISK ASSESSMENT 
          TABLE 2 RISK ASSESSMENT
    2.7 RECESSION IMPACT ON MARKET 
 
3 EXECUTIVE SUMMARY (Page No. - 41)
    FIGURE 10 MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 11 THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 44)
    4.1 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET OVERVIEW 
          FIGURE 13 RISING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET
    4.2 ASIA PACIFIC: MARKET, BY PRODUCT AND COUNTRY (2022) 
          FIGURE 14 COOLING DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
    4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 MARKET: REGIONAL MIX 
          FIGURE 16 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
    4.5 MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 48)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 18 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Rising population and increasing prevalence of chronic and infectious diseases
                    5.2.1.2 Increasing number of surgical procedures
                    5.2.1.3 Rising number of hypothermia cases
                    5.2.1.4 Growing number of trauma cases
                    5.2.1.5 Rising adoption of minimally invasive cooling methods
                    5.2.1.6 Growing demand for targeted temperature management in cardiac arrest
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of awareness regarding therapeutic hypothermia systems in developing countries
                    5.2.2.2 Availability of alternative methods
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing growth opportunities in emerging economies
                    5.2.3.2 Developing healthcare infrastructure
                    5.2.3.3 Growing number of contracts and agreements between market players
           5.2.4 CHALLENGES
                    5.2.4.1 Lack of skilled healthcare professionals
                    5.2.4.2 Lack of proper supply chain management
                    5.2.4.3 Product recalls
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
    5.4 SUPPLY CHAIN ANALYSIS 
          FIGURE 20 DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
    5.5 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 3 PORTER’S FIVE FORCES ANALYSIS: THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY
           5.5.1 INTENSITY OF COMPETITIVE RIVALRY
           5.5.2 BARGAINING POWER OF SUPPLIERS
           5.5.3 BARGAINING POWER OF BUYERS
           5.5.4 THREAT OF SUBSTITUTES
           5.5.5 THREAT OF NEW ENTRANTS
    5.6 REGULATORY ANALYSIS 
          TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THERAPEUTIC HYPOTHERMIA SYSTEMS
           5.6.1 NORTH AMERICA
                    5.6.1.1 US
                                TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
                                FIGURE 21 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES
                    5.6.1.2 Canada
                                FIGURE 22 CANADA: APPROVAL PROCESS FOR MEDICAL DEVICES
           5.6.2 EUROPE
                    FIGURE 23 CE APPROVAL PROCESS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
           5.6.3 ASIA PACIFIC
                    5.6.3.1 Japan
                                TABLE 6 JAPAN: CLASSIFICATION OF MEDICAL DEVICES
                    5.6.3.2 China
                                TABLE 7 NMPA MEDICAL DEVICES CLASSIFICATION
                    5.6.3.3 India
    5.7 TRADE ANALYSIS 
           5.7.1 TRADE ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
                    TABLE 8 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
                    TABLE 9 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
    5.8 TECHNOLOGY ANALYSIS 
    5.9 ECOSYSTEM ANALYSIS 
          FIGURE 24 SYSTEMS MARKET: ECOSYSTEM ANALYSIS
           5.9.1 ROLE IN ECOSYSTEM
                    FIGURE 25 KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS ECOSYSTEM
    5.10 PATENT ANALYSIS 
           FIGURE 26 PATENT ANALYSIS FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
    5.11 KEY CONFERENCES AND EVENTS IN 2024–2025 
           TABLE 10 LIST OF CONFERENCES AND EVENTS IN 2024–2025
    5.12 PRICING ANALYSIS 
           TABLE 11 AVERAGE SELLING PRICE OF KEY PRODUCTS IN MARKET (2019–2022)
           TABLE 12 AVERAGE SELLING PRICE TRENDS, BY REGION, 2019–2022
    5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 
           5.13.1 REVENUE SHIFT & REVENUE POCKETS FOR THERAPEUTIC HYPOTHERMIA SYSTEM MANUFACTURERS
                     FIGURE 27 REVENUE SHIFT FOR THERAPEUTIC HYPOTHERMIA SYSTEMS
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
                     TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOSPITALS
           5.14.2 BUYING CRITERIA
                     FIGURE 29 KEY BUYING CRITERIA FOR TOP END USERS
                     TABLE 14 KEY BUYING CRITERIA, BY TOP END USER
 
6 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT (Page No. - 74)
    6.1 INTRODUCTION 
          TABLE 15 THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 COOLING DEVICES 
           6.2.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE DEMAND
                    TABLE 16 THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 17 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 18 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 19 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 20 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.3 COOLING CATHETERS 
           6.3.1 ABILITY TO COOL SPECIFIC AREAS EFFICIENTLY TO SUPPORT MARKET GROWTH
                    TABLE 21 THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 22 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 23 EUROPE: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 24 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 25 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOLING CATHETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
    6.4 COOL CAPS 
           6.4.1 INCREASING NUMBER OF CHEMOTHERAPY PROCEDURES TO DRIVE DEMAND
                    TABLE 26 THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 27 NORTH AMERICA: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 28 EUROPE: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 29 ASIA PACIFIC: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 30 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA COOL CAPS MARKET, BY REGION, 2021–2028 (USD MILLION)
 
7 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION (Page No. - 84)
    7.1 INTRODUCTION 
          TABLE 31 THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY, BY APPLICATION, 2021–2028 (USD MILLION)
    7.2 NEUROLOGY 
           7.2.1 GROWING PREVALENCE OF TBI AND OTHER NEUROLOGICAL DISEASES TO DRIVE MARKET
                    TABLE 32 MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 33 NORTH AMERICA: MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 34 EUROPE: MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 35 ASIA PACIFIC: MARKET FOR NEUROLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 36 REST OF THE WORLD: MARKET FOR NEUROLOGY, BY REGION, 2021–2028 (USD MILLION)
    7.3 CARDIOLOGY 
           7.3.1 HIGH INCIDENCE OF CARDIAC ARRESTS TO SUPPORT MARKET GROWTH
                    TABLE 37 MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 38 NORTH AMERICA: MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 39 EUROPE: MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 40 ASIA PACIFIC: MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 41 REST OF THE WORLD: MARKET FOR CARDIOLOGY, BY REGION, 2021–2028 (USD MILLION)
    7.4 NEONATAL CARE 
           7.4.1 INCREASING NUMBER OF PRETERM BIRTHS TO SUPPORT MARKET GROWTH
                    TABLE 42 MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 43 NORTH AMERICA: MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 44 EUROPE: MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 45 ASIA PACIFIC: MARKET FOR NEONATAL CARE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 46 REST OF THE WORLD: MARKET FOR NEONATAL CARE, BY REGION, 2021–2028 (USD MILLION)
    7.5 OTHER APPLICATIONS 
          TABLE 47 MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 48 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 49 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 50 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 51 REST OF THE WORLD: MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
 
8 THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION (Page No. - 96)
    8.1 INTRODUCTION 
          TABLE 52 THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY, BY REGION, 2021–2028 (USD MILLION)
    8.2 NORTH AMERICA 
          FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT
           8.2.1 NORTH AMERICA: RECESSION IMPACT
                    TABLE 53 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 54 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 55 NORTH AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.2.2 US
                    8.2.2.1 Growing number of cardiac arrest and brain injury cases to support market growth
                                TABLE 56 US: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 57 US: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 58 US: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
           8.2.3 CANADA
                    8.2.3.1 Increasing incidence of various chronic diseases to drive market
                                TABLE 59 CANADA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 60 CANADA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.3 EUROPE 
           8.3.1 EUROPE: RECESSION IMPACT
                    TABLE 61 EUROPE: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 63 EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.3.2 GERMANY
                    8.3.2.1 High demand for patient cooling devices for cardiology procedures to drive market
                                TABLE 64 GERMANY: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 65 GERMANY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 66 GERMANY: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
           8.3.3 UK
                    8.3.3.1 Rising number of sports injuries and accident & emergency procedures to drive market
                                TABLE 67 UK: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 68 UK: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 69 UK: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
           8.3.4 FRANCE
                    8.3.4.1 Strong healthcare system to support market growth
                                TABLE 70 FRANCE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 71 FRANCE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 72 FRANCE: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
           8.3.5 ITALY
                    8.3.5.1 Growing demand for therapeutic hypothermia systems in traumatic brain injury treatment to support market growth
                                TABLE 73 ITALY: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 74 ITALY: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.3.6 SPAIN
                    8.3.6.1 Growing geriatric population and subsequent increase in prevalence of target conditions to drive market
                                TABLE 75 SPAIN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 76 SPAIN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.3.7 REST OF EUROPE
                    TABLE 77 REST OF EUROPE: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 78 REST OF EUROPE: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.4 ASIA PACIFIC 
          FIGURE 31 ASIA PACIFIC: MARKET SNAPSHOT
           8.4.1 ASIA PACIFIC: RECESSION IMPACT
                    TABLE 79 ASIA PACIFIC: MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 80 ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 81 ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.4.2 CHINA
                    8.4.2.1 Increasing disposable income of middle-class population to drive market
                                TABLE 82 CHINA: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 83 CHINA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 84 CHINA: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
           8.4.3 JAPAN
                    8.4.3.1 Rapidly increasing geriatric population to drive market
                                TABLE 85 JAPAN: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 86 JAPAN: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                TABLE 87 JAPAN: THERAPEUTIC HYPOTHERMIA COOLING DEVICES MARKET, BY VOLUME, 2021–2028 (THOUSAND UNITS)
           8.4.4 INDIA
                    8.4.4.1 Growing target patient population to support market growth
                                TABLE 88 INDIA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 89 INDIA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.4.5 REST OF ASIA PACIFIC
                    TABLE 90 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 91 REST OF ASIA PACIFIC: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.5 REST OF THE WORLD 
           8.5.1 REST OF THE WORLD: RECESSION IMPACT
                    TABLE 92 REST OF THE WORLD: THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 93 REST OF THE WORLD: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                    TABLE 94 REST OF THE WORLD: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.5.2 LATIN AMERICA
                    8.5.2.1 Rising prevalence of chronic diseases to drive market
                                TABLE 95 LATIN AMERICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 96 LATIN AMERICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.5.3 MIDDLE EAST & AFRICA
                    8.5.3.1 High prevalence of chronic conditions to support market growth
                                TABLE 97 MIDDLE EAST & AFRICA: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 98 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
           8.5.4 GCC COUNTRIES
                    8.5.4.1 Rise in road accident injuries and TBI to drive market
                                TABLE 99 GCC COUNTRIES: MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                TABLE 100 GCC COUNTRIES: MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
 
9 COMPETITIVE LANDSCAPE (Page No. - 128)
    9.1 OVERVIEW 
    9.2 STRATEGIES ADOPTED BY KEY PLAYERS 
          TABLE 101 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET
    9.3 REVENUE ANALYSIS 
          FIGURE 32 REVENUE ANALYSIS FOR KEY COMPANIES IN THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY, 2018–2022 (USD MILLION)
    9.4 MARKET SHARE ANALYSIS 
          FIGURE 33 MARKET RANKING ANALYSIS, BY KEY PLAYER (2022)
          TABLE 102 MARKET: DEGREE OF COMPETITION
    9.5 COMPANY EVALUATION MATRIX 
           9.5.1 STARS
           9.5.2 EMERGING LEADERS
           9.5.3 PERVASIVE PLAYERS
           9.5.4 PARTICIPANTS
                    FIGURE 34 THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY: COMPANY EVALUATION MATRIX, 2022
           9.5.5 COMPANY FOOTPRINT
                    TABLE 103 PRODUCT FOOTPRINT (11 PLAYERS)
                    TABLE 104 REGIONAL FOOTPRINT (11 PLAYERS)
                    TABLE 105 OVERALL COMPANY FOOTPRINT (11 PLAYERS)
    9.6 STARTUP/SME EVALUATION MATRIX 
           9.6.1 PROGRESSIVE COMPANIES
           9.6.2 STARTING BLOCKS
           9.6.3 RESPONSIVE COMPANIES
           9.6.4 DYNAMIC COMPANIES
                    FIGURE 35 THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY: STARTUP/SME EVALUATION MATRIX, 2022
           9.6.5 COMPETITIVE BENCHMARKING
                    TABLE 106 THERAPEUTIC HYPOTHERMIA SYSTEMS INDUSTRY: DETAILED LIST OF KEY STARTUPS/SMES
                    TABLE 107 PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES)
                    TABLE 108 REGIONAL FOOTPRINT (STARTUPS/SMES)
                    TABLE 109 OVERALL COMPANY FOOTPRINT (STARTUPS/SMES)
    9.7 COMPETITIVE SCENARIO AND TRENDS 
           9.7.1 DEALS
                    TABLE 110 THERAPEUTIC HYPOTHERMIA SYSTEMS: DEALS, JANUARY 2020–NOVEMBER 2023
           9.7.2 OTHER DEVELOPMENTS
                    TABLE 111 THERAPEUTIC HYPOTHERMIA SYSTEMS: OTHER DEVELOPMENTS, JANUARY 2020–NOVEMBER 2023
 
10 COMPANY PROFILES (Page No. - 141)
     10.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
             10.1.1 ASAHI KASEI CORPORATION (ZOLL MEDICAL CORPORATION)
                        TABLE 112 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
             10.1.2 BECTON, DICKINSON AND COMPANY
                        TABLE 113 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
             10.1.3 GENTHERM INCORPORATED
                        TABLE 114 GENTHERM INCORPORATED: BUSINESS OVERVIEW
                        FIGURE 38 GENTHERM INCORPORATED: COMPANY SNAPSHOT (2022)
             10.1.4 STRYKER CORPORATION
                        TABLE 115 STRYKER CORPORATION: BUSINESS OVERVIEW
                        FIGURE 39 STRYKER CORPORATION: COMPANY SNAPSHOT (2022)
             10.1.5 BELMONT MEDICAL TECHNOLOGIES
                        TABLE 116 BELMONT MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
             10.1.6 INTERNATIONAL BIOMEDICAL LTD.
                        TABLE 117 INTERNATIONAL BIOMEDICAL LTD.: BUSINESS OVERVIEW
             10.1.7 EM-MED
                        TABLE 118 EM-MED: BUSINESS OVERVIEW
             10.1.8 PHOENIX MEDICAL SYSTEMS
                        TABLE 119 PHOENIX MEDICAL SYSTEMS: BUSINESS OVERVIEW
             10.1.9 LIFE RECOVERY SYSTEMS
                        TABLE 120 LIFE RECOVERY SYSTEMS: BUSINESS OVERVIEW
             10.1.10 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
                        TABLE 121 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.: BUSINESS OVERVIEW
             10.1.11 MIRACRADLE (PLUSS ADVANCED TECHNOLOGIES PVT. LTD.)
                        TABLE 122 MIRACRADLE: BUSINESS OVERVIEW
     10.2 OTHER PLAYERS 
             10.2.1 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
                        TABLE 123 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY OVERVIEW
             10.2.2 PFM MEDICAL HICO GMBH
                        TABLE 124 PFM MEDICAL HICO GMBH: COMPANY OVERVIEW
             10.2.3 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.
                        TABLE 125 VNG MEDICAL INNOVATION SYSTEM PVT. LTD.: COMPANY OVERVIEW
             10.2.4 ASPEN SYSTEMS
                        TABLE 126 ASPEN SYSTEMS: COMPANY OVERVIEW
             10.2.5 COOLTECH MEDICAL
                        TABLE 127 COOLTECH MEDICAL: COMPANY OVERVIEW
             10.2.6 GLOBAL HEALTHCARE SG
                        TABLE 128 GLOBAL HEALTHCARE SG: COMPANY OVERVIEW
             10.2.7 CRYOTHERMIC SYSTEMS INCORPORATED
                        TABLE 129 CRYOTHERMIC SYSTEMS INCORPORATED: COMPANY OVERVIEW
             10.2.8 PAXMAN COOLERS LTD.
                        TABLE 130 PAXMAN COOLERS LTD.: COMPANY OVERVIEW
             10.2.9 DIGNITANA AB
                        TABLE 131 DIGNITANA AB: COMPANY OVERVIEW
             10.2.10 WISHCAPS
                        TABLE 132 WISHCAPS: COMPANY OVERVIEW
 
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
 
11 APPENDIX (Page No. - 166)
     11.1 DISCUSSION GUIDE 
     11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     11.3 CUSTOMIZATION OPTIONS 
     11.4 RELATED REPORTS 
     11.5 AUTHOR DETAILS 

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the therapeutic hypothermia systems market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as pharmaceutical & biotechnology industries, food & nutraceutical industries, and research laboratories) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Therapeutic Hypothermia  Systems Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various therapeutic hypothermia systems were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value therapeutic hypothermia systems market was also split into various segments and subsegments at the region and country level based on:

  • Product mapping of various manufacturers for each type of market at the regional and country level 
  • Relative adoption pattern of each market among key application segments at the regional and/or country-level 
  • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
  • Detailed secondary research to gauge the prevailing market trends at the regional and/or country level 

Global Therapeutic Hypothermia Systems Market Size: Top-Down Approach

Therapeutic Hypothermia  Systems Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Therapeutic Hypothermia Systems Market Size: Bottom-Up Approach

Therapeutic Hypothermia  Systems Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Therapeutic hypothermia systems industry.

Market Definition

Therapeutic hypothermia, also known as targeted temperature management or induced hypothermia, is a medical treatment that involves lowering a patient’s body temperature for a specific period to provide therapeutic benefits. This intervention is often employed in certain medical conditions to reduce the risk of injury to tissues, particularly the brain, and improve overall outcomes. The primary goal of therapeutic hypothermia is to protect the body’s organs, especially the brain, from damage following events such as cardiac arrest, traumatic brain injury, stroke, or neonatal hypoxic-ischemic encephalopathy (a type of brain injury that occurs when there is a lack of oxygen and blood flow to the brain in newborns).

Key Stakeholders

  • Senior Management
  • Finance/Procurement Department
  • R&D Department
  • Surgeons and Anesthesiologists/Paramedical Staff/Nursing Staff

Report Objectives

  • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To define, describe, segment, and forecast the therapeutic hypothermia systems market by product, application, and region
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Rest of the world.
  • To profile key players in the market and comprehensively analyze their core competencies and market shares
  • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the market.
  • To benchmark players within the market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the Therapeutic hypothermia systems market
  • Profiling of additional market players (up to 5)

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Therapeutic hypothermia systems Market
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization
Report Code
MD 8924
Published ON
Jan, 2024
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Therapeutic Hypothermia Systems Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback